Synthesis and structure-activity relationship of 3-hydroxypyridine-2- thione-based histone deacetylase inhibitors

Quaovi H. Sodji, Vishal Patil, James R. Kornacki, Milan Mrksich, Adegboyega K. Oyelere*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

We previously identified 3-hydroxypyridine-2-thione (3HPT) as a novel zinc binding group for histone deacetylase (HDAC) inhibition. Early structure-activity relationship (SAR) studies led to various small molecules possessing selective inhibitory activity against HDAC6 or HDAC8 but devoid of HDAC1 inhibition. To delineate further the depth of the SAR of 3HPT-derived HDAC inhibitors (HDACi), we have extended the SAR studies to include the linker region and the surface recognition group to optimize the HDAC inhibition. The current efforts resulted in the identification of two lead compounds, 10d and 14e, with potent HDAC6 and HDAC8 activities that are inactive against HDAC1. These new HDACi possess anticancer activities against various cancer cell lines including Jurkat J.γ1 for which SAHA and the previously disclosed 3HPT-derived HDACi were inactive.

Original languageEnglish (US)
Pages (from-to)9969-9981
Number of pages13
JournalJournal of Medicinal Chemistry
Volume56
Issue number24
DOIs
StatePublished - Dec 27 2013

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint Dive into the research topics of 'Synthesis and structure-activity relationship of 3-hydroxypyridine-2- thione-based histone deacetylase inhibitors'. Together they form a unique fingerprint.

Cite this